Clinical trial
Prospective, Longitudinal Study of 800 Recreational Athletes With Current and Former Use of Performance and Image Enhancing Drugs (PIED), Focusing on Androgenic Anabolic Steroids (AAS) - Rigshospitalet
NCT05599438 is registered in ClinicalTrials.gov with Caroline Michaela Kistorp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Longitudinal Study of 800 Recreational Athletes With Current and Former Use of Performance and Image Enhancing Drugs (PIED), Focusing on Androgenic Anabolic Steroids (AAS) - Rigshospitalet
- Lead sponsor
- Caroline Michaela Kistorp
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 14, 2022
- Completion date
- June 1, 2040
- Enrollment
- 900 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anabolic steroid overdose, cardiovascular complication, fitness, illicit drug use, infertility, mental health issue